Publication: Ischaemic stroke complicating primary percutaneous coronary intervention in patients with ST elevation myocardial infarction
| dc.contributor.authors | Ergelen, Mehmet; Gorgulu, Sevket; Uyarel, Huseyin; Norgaz, Tugrul; Ayhan, Erkan; Akkaya, Emre; Ergelen, Rabia; Cicek, Gokhan; Ugur, Murat; Soylu, Ozer; Tezel, Tuna; Yekeler, Ibrahim | |
| dc.date.accessioned | 2022-03-12T17:46:58Z | |
| dc.date.accessioned | 2026-01-11T07:59:48Z | |
| dc.date.available | 2022-03-12T17:46:58Z | |
| dc.date.issued | 2009 | |
| dc.description.abstract | Objective - We sought to determine the in-hospital incidence and predictors of ischaemic stroke in patients with ST elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Methods - We reviewed 2638 consecutive patients undergoing 2722 pimary PCI procedures for STEMI during in-hospital stay. Stroke was defined as any new focal neurological deficit lasting >= 24 h, occurring anytime during or after PCI until discharge. Patients with haemorrhagic stroke were excluded. Clinical characteristics and in-hospital outcome were analysed regarding ischaemic stroke in patients undergoing primary PCI. Results - Ischaemic stroke was observed in 20 of the 2722 procedures, an incidence of 0.73%. Patients with ischaemic stroke were older than patients without stroke (mean age 67 +/- 9.6 vs. 56.6 +/- 11.8, P < 0.001). Compared to patients without stroke, female gender, diabetes and hypertension were more prevalent in patients with stroke. Ischaemic stroke was found to be a powerful independent predictor of in-hospital cardiovascular mortality (odds ratio [OR] 6.32, 1.15-34.7; P < 0.001). Left ventricular ejection fraction (LVEF) < 35% (OR 3.13, P = 0.04), contrast-induced nephropathy (OR 2.91, P = 0.04) and tirofiban use (OR 0.23, P = 0.02) were the independent predictors for in-hospital ischaemic stroke. Conclusions - The present Study shows that the incidence of ischaemic stroke in patients undergoing PCI for STEMI is higher and ischaemic stroke increases in-hospital mortality in these patients. Moreover, LVEF < 35% and contrast-induced nephropathy were independent predictors of ischaemic stroke, whereas tirofiban use demonstrated a protective effect to this potentially catastrophic complication. | |
| dc.identifier.doi | 10.2143/AC.64.6.2044735 | |
| dc.identifier.eissn | 1784-973X | |
| dc.identifier.issn | 0001-5385 | |
| dc.identifier.pubmed | 20128147 | |
| dc.identifier.uri | https://hdl.handle.net/11424/229621 | |
| dc.identifier.wos | WOS:000273486700003 | |
| dc.language.iso | eng | |
| dc.publisher | TAYLOR & FRANCIS LTD | |
| dc.relation.ispartof | ACTA CARDIOLOGICA | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | ST elevation myocardial infarction | |
| dc.subject | primary percutaneous coronary intervention | |
| dc.subject | ischaemic stroke | |
| dc.subject | prognosis | |
| dc.subject | primary angioplasty | |
| dc.subject | tirofiban | |
| dc.subject | mortality | |
| dc.subject | CLINICAL FINDINGS | |
| dc.subject | GLOBAL REGISTRY | |
| dc.subject | RISK-FACTORS | |
| dc.subject | THROMBOLYSIS | |
| dc.subject | ANGIOPLASTY | |
| dc.subject | MORTALITY | |
| dc.subject | OUTCOMES | |
| dc.subject | EVENTS | |
| dc.subject | REVASCULARIZATION | |
| dc.subject | MANAGEMENT | |
| dc.title | Ischaemic stroke complicating primary percutaneous coronary intervention in patients with ST elevation myocardial infarction | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 734 | |
| oaire.citation.issue | 6 | |
| oaire.citation.startPage | 729 | |
| oaire.citation.title | ACTA CARDIOLOGICA | |
| oaire.citation.volume | 64 |
